A small molecule divertin was identified previously through screening that blocked acute TNF-induced MLCK1 recruitment, downstream myosin light chain (MLC) phosphorylation, barrier dysfunction, and diarrhea in vitro and in vivo, and inhibited the progression of experimental IBD (Graham et al., 2019). Here, TNF is linked to inflammatory bowel disease.